As rates of obesity have steadily climbed over the past 40 years, more adolescents and young adults are being diagnosed with type 2 diabetes than ever before. Between 2002 and 2012 alone, the incidence of type 2 diabetes in youth grew by nearly 5%. As early onset has been directly linked to poorer outcomes, young adults diagnosed with diabetes face higher risks for long-term complications.
With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing epidemic of cardiovascular diseases through sessions spotlighting the most recent and relevant research.